Gyre Therapeutics
GYRE
GYRE
41 hedge funds and large institutions have $21.6M invested in Gyre Therapeutics in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
7% more capital invested
Capital invested by funds: $20.2M → $21.6M (+$1.44M)
0.36% more ownership
Funds ownership: 1.72% → 2.08% (+0.36%)
Holders
41
Holding in Top 10
–
Calls
$1.06M
Puts
$16K
Top Buyers
| 1 | +$647K | |
| 2 | +$268K | |
| 3 | +$209K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$104K |
| 5 |
Goldman Sachs
New York
|
+$91.8K |
Top Sellers
| 1 | -$215K | |
| 2 | -$214K | |
| 3 | -$36.1K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$30.1K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$6.69K |